Analysts Have Conflicting Sentiments on These Healthcare Companies: Ocular Therapeutix (OCUL) and ModivCare (MODV)
ModivCare Analyst Ratings
Lake Street Reaffirms Their Hold Rating on ModivCare (MODV)
ModivCare Analyst Ratings
Lake Street Downgrades ModivCare to Hold From Buy, Cuts Price Target to $50 From $100
ModivCare Analyst Ratings
ModivCare's Challenging Outlook: Operational Headwinds Prompt Hold Rating
ModivCare: Hold Rating Justified by Mixed Performance and Cautious FY24 Outlook Amid Contract Challenges
ModivCare Analyst Ratings
Barrington Raises Price Target on ModivCare to $68 From $58, Maintains Outperform Rating
Analysts' Top Healthcare Picks: ModivCare (MODV), Clearside Biomedical (CLSD)
ModivCare Earns Buy Rating From Analyst Michael Petusky Amidst Q3 Profitability and Bright Future Prospects
Analysts Offer Insights on Healthcare Companies: ModivCare (MODV), Alcon (ALC) and Humana (HUM)
Analysts' Opinions Are Mixed on These Healthcare Stocks: Bausch + Lomb Corporation (BLCO), ModivCare (MODV) and Staar Surgical (STAA)
ModivCare's Stock: A Buy Rating Based on Revenue Growth, Cash Flow Improvement, and Management's Forecasting Proficiency
Barrington Sticks to Their Buy Rating for ModivCare (MODV)
Lake Street Adjusts ModivCare Price Target to $100 From $135, Maintains Buy Rating
Deutsche Bank Maintains Buy on ModivCare, Lowers Price Target to $50
ModivCare Analyst Ratings
ModivCare (MODV) Receives a Buy From Barrington
No Data